Every SEC Form 3/4/5 on record for this filer (CIK 1237556) — 4 issuers, 175 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| OABI | OmniAb, Inc. | President and CEO · Director | 2022-11-03 → 2026-04-07 | 35 | $7M |
| VKTX | Viking Therapeutics, Inc. | Director | 2016-01-06 → 2026-01-05 | 18 | −$391,830 |
| LGND | LIGAND PHARMACEUTICALS INC | President and COO · lapsed | 2016-02-16 → 2022-11-03 | 40 | −$26M |
| RTTR | RITTER PHARMACEUTICALS INC | Director · lapsed | 2015-10-15 → 2020-04-23 | 11 | $113,064 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| OABI | 2026-04-07 | Sell | 19,244 | $1.49 | $28,674 | 4,420,492 |
| OABI | 2026-02-18 | Sell | 30,843 | $1.71 | $52,742 | 4,403,277 |
| OABI | 2026-02-17 | Sell | 20,754 | $1.70 | $35,282 | 4,375,787 |
| VKTX | 2026-01-02 | Sell | 16,000 | $35.11 | $561,760 | 132,036 |
| OABI | 2025-12-08 | Sell | 13,666 | $1.96 | $26,785 | 4,360,083 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.
